Edition:
United Kingdom

Towa Pharmaceutical Co Ltd (4553.T)

4553.T on Tokyo Stock Exchange

7,890JPY
17 Jan 2019
Change (% chg)

-- (--)
Prev Close
¥7,890
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
74,556
52-wk High
¥9,280
52-wk Low
¥5,780

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 17 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 4 4 4 4
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.83 2.83 2.83 2.83

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 25,300.00 25,300.00 25,300.00 --
Year Ending Mar-19 5 102,460.00 103,000.00 101,600.00 97,880.00
Year Ending Mar-20 5 108,660.00 110,500.00 107,600.00 103,780.00
Earnings (per share)
Year Ending Mar-19 6 564.12 597.50 530.39 351.56
Year Ending Mar-20 6 573.65 615.70 499.91 366.10
LT Growth Rate (%) 1 14.30 14.30 14.30 --

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 23,603.00 23,645.00 42.00 0.18
Quarter Ending Jun-18 23,533.30 25,494.00 1,960.67 8.33
Quarter Ending Mar-18 23,354.70 23,018.00 336.67 1.44
Quarter Ending Dec-17 25,651.00 25,714.00 63.00 0.25
Quarter Ending Sep-17 22,993.50 22,185.00 808.50 3.52

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 25,300.00 25,300.00 25,300.00 25,300.00 --
Year Ending Mar-19 102,460.00 102,460.00 102,460.00 101,600.00 97,880.00
Year Ending Mar-20 108,660.00 108,660.00 108,660.00 107,640.00 103,780.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0
Earnings